Spend less time searching for high-level courses in your specialty area and more time gaining the skills that will help you to deliver first class patient care at any stage of your career with the new EUFOREA e-Academy.
From pathophysiology and clinical examination, to differential diagnoses and follow up, the new EUFOREA e-Academy offers introductory courses (for specialists in training, general practitioners and pharmacists), advanced courses (for specialists and specialists in training), and courses in the latest innovations (for specialists and tertiary care specialists) in the areas of :
- Asthma
- Chronic Rhinosinusitis (CRS)
- Allergic Rhinitis (AR)
- Allergen Immunotherapy (AIT)
What we offer:
- Self-paced courses for flexible learning
- Up-to-date, evidence-based content developed by EUFOREA’s network of global experts
- Interactive learning self-assessments to test your knowledge
- EUFOREA certificate earned upon successful course completion
Access full academy Access full academy
Since 2015, tens of thousands of healthcare professionals from across the globe have trusted EUFOREA as a provider of high quality, evidence-based continuing medical education. As medical science continues to evolve rapidly, physicians continue to face growing pressure to stay up-to-date with the latest innovations and therapies which will allow them to deliver best-in-class care for patients suffering from allergies and airway diseases.
The EUFOREA e-Academy offers a one-stop resource for:
- Flexible on-demand educational content
- Up-to-date learning sessions led by world experts
- Access to offline resources that will enhance knowledge building
About us
EUFOREA is an international nonprofit organisation forming an alliance of all stakeholders from national and international organisations, institutions, and agencies with the common target to implement optimal patient care for allergies and airway diseases (asthma, chronic rhinosinusitis, rhinitis) and comorbidities.
EUFOREA proposes to reduce the preventable and avoidable burden of morbidity and disability due to allergies and airway diseases by means of a multidisciplinary, practical approach so that populations reach the highest attainable standards of health and productivity at every age and that those diseases are no longer a barrier to well-being or socio-economic development.
Patient Education
